Susquehanna International Group’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-538
| Closed | -$34.5K | – | 6253 |
|
|
2024
Q3 | $34.5K | Sell |
538
-987
| -65% | -$63.3K | ﹤0.01% | 5341 |
|
|
2024
Q2 | $114K | Buy |
1,525
+930
| +156% | +$69.8K | ﹤0.01% | 5049 |
|
|
2024
Q1 | $71K | Buy |
+595
| New | +$71K | ﹤0.01% | 5102 |
|
|
2022
Q1 | – | Sell |
-168
| Closed | -$33K | – | 5826 |
|
|
2021
Q4 | $33K | Buy |
+168
| New | +$33K | ﹤0.01% | 5555 |
|
|
2020
Q2 | – | Sell |
-186
| Closed | -$71K | – | 4322 |
|
|
2020
Q1 | $71K | Buy |
+186
| New | +$71K | ﹤0.01% | 4128 |
|
|
2018
Q1 | – | Sell |
-165
| Closed | -$678K | – | 3513 |
|
|
2017
Q4 | $678K | Buy |
+165
| New | +$678K | ﹤0.01% | 2133 |
|
|
2017
Q2 | – | Sell |
-4
| Closed | -$29K | – | 3617 |
|
|
2017
Q1 | $29K | Sell |
4
-45
| -92% | -$326K | ﹤0.01% | 3093 |
|
|
2016
Q4 | $179K | Buy |
+49
| New | +$179K | ﹤0.01% | 3751 |
|